title: Pyridoxine or pyridoxal-5'-phosphate for neonatal epilepsy: the distinction just got murkier.
authors.affiliation: From the Department of Neurology (P.L.P.), Children's National Medical Center, The George Washington University School of Medicine, Washington, DC; the Departments of Neurology and Pediatrics (S.M.G.), University of Washington, Seattle; and the Division of Neurology (S.M.G.), Seattle Children's Hospital, WA.
authors.forename: Phillip L
authors.initials: PL
authors.lastname: Pearl
authors.forename: Sidney M
authors.initials: SM
authors.lastname: Gospe
mesh_terms: D000818:Animals; D001928:Brain Diseases, Metabolic / Q000188:drug therapy* / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D011734:Pyridoxaminephosphate Oxidase / Q000172:deficiency* / Q000235:genetics; D011736:Pyridoxine / Q000627:therapeutic use*; D012640:Seizures / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D011734:Pyridoxaminephosphate Oxidase; D011736:Pyridoxine